Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
clinical study
data
disease
enzyme
gag
gene editing
genome editing
hunter syndrome
ids
life sciences
mps ii
mucopolysaccharidosis ii
national blog main
national top stories
san francisco
san francisco blog main
san francisco top stories
sandy macrae
sangamo therapeutics
studies
zinc finger nucleases
What
isn't
2
×
medicine
2
×
results
2
×
analysed
benefit
benefits
big
broken
design
designed
dlc
drugs
editing
evil
exaggerate
favour
flawed
gene
going
hopelessly
humans
landmark
little
malpractice
manufacture
marketing
morning
nasdaq
numbers
patients
people
pharma
phase
poorly
produce
reported
reports
sangamo
small
studies
Language
Current search:
isn't
×
results
×
medicine
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@eurogamer.net
7 years ago
Even with the Marketing and Malpractice DLC, Big Pharma just isn't evil enough
